Dopamine receptor occupancy in vivo: behavioral correlates using NNC-112, NNC-687 and NNC-756, new selective dopamine D1 receptor antagonists

Add time:08/25/2019    Source:sciencedirect.com

The ability of dopamine D2, mixed D1/D2 and selective D1 receptor antagonists, including NNC-112, NNC-687, NNC-756, to inhibit the in vivo binding of [3H]SCH 23390 or [3H]raclopride to dopamine receptors was studied in mice and rats. Furthermore, the dopamine-antagonistic effects of these drugs were also studied in varioous behavioural models. Significant levels of in vivo receptor blockade were required for antagonism of typical dopamine agonist-mediated behaviors. However, fewer D1 than D2 receptors had to be blocked to produce similar antagonistic effects. Thus, there may be a greater receptor reserve for D2 receptors than for D1 receptors.

We also recommend Trading Suppliers and Manufacturers of NNC 687 (cas 128022-68-4). Pls Click Website Link as below: cas 128022-68-4 suppliers

Prev:[11C]NNC 687 (cas 128022-68-4) and [11C]NNC 756, dopamine D-1 receptor ligands. Preparation, autoradiography and PET investigation in monkey
Next:Original Articles[11C]NNC 22-0215, a Metabolically Stable Dopamine D1 Radioligand for PET)